Chronic obstructive pulmonary disease Respiratory
Conditions
Interventions
None listed
Sponsors
King's College London
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Category A - Inclusion criteria of participating pulmonary rehabilitation sites: 1. > 200 pulmonary rehabilitation referrals per year to allow for at least 35 (17.5%) participants to be recruited over six months. 2. Conduct routine baseline and final pulmonary rehabilitation session data including uptake and completion rates, quality of life assessment (COPD Assessment Test-CAT or Chronic Respiratory Questionnaire -CRQ-SAS), exercise tests (Six Minute Walking Distance - 6MWD or Intermittent Shuttle Walk Test - ISWT), and well-being assessment (General Anxiety Disorder Assessment 7 – GAD7) and (Patient Health Questionnaire 9 -PHQ9 or Hospital Anxiety and Depression Scale HADS). 3. Completion rate 2 5. Consent to be randomised to intervention or usual care arm of the trial 6. Consent to receive telephone contact by PRB and to mee
Exclusion criteria
Exclusion criteria: Category A - Exclusion criteria of participating pulmonary rehabilitation sites: 1. Unable to join trial until after June 2023 2. Unable to identify at least three members of staff for the trial willing to consent to participation 3. Local trust R&D office unwilling to support the trial Category B - Exclusion criteria of pulmonary rehabilitation site participating staff: 1. Will not be employed in their post for the duration of the trial at the site in question Category C - Exclusion criteria of pulmonary rehabilitation buddy volunteers 1. Unable to participate for the duration of the trial at the site in question 2. Unable to travel independently to meet referred patients 3. Unable or unwilling to use a smart mobile phone 4. Unable to give valid consent 5. Failed DBS check Category D - Exclusion criteria of participating patients 1. Poorly controlled angina on minimal exertion 2. Myocardial infarction in 6 weeks prior to commencement of the programme 3. Breathlessness as a result of cardiac disease. 4. Uncontrolled hypertension 5. Any medical problem that severely restricts exercise or compliance with the programme e.g. severe arthritis or dementia 6. Unable to give valid consent 7. Unable to join until after month 20 of the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Uptake rate and completion of pulmonary rehabilitation, completion defined as attendance of 70% or more of the planned classes, measured using patient records at month 33 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Recruit and retain 38 pulmonary rehabilitation centres measured using study records at month 13 (for recruitment) and at month 26 (for retention) 2. Assess recruitment and retention of patient participants measured using study records between months 25 and 31 3. Rates of improvement in: 3.1. Exercise capacity and symptoms measured using: 3.1.1. The COPD assessment test (CAT) at baseline, 3 and 6 months post-assessment 3.1.2. The 6-minute walking distance test and incremental shuttle walk test prior to and after the end of pulmonary rehabilitation 3.2. Quality of life measured using the Euroqol EQ-5D-5L questionnaire at baseline, 3 and 6 months post-assessment 3.3. Well-being measured using the Hospital anxiety and depression survey (HADS) at baseline, 3 and 6 months post-assessment | — |
Countries
England, United Kingdom
Contacts
Public ContactToby Morgan
Outcome results
None listed